Neurological and psychological symptoms associated with COVID-19 infection, such as fatigue and depression, are more common in those with mild coronavirus infection than previously believed.
Following a TBI, the risk of having a stroke is significantly increased for the first four months post-injury. The risk of stroke remains elevated for up to five years following a head injury.
Adding icosapent ethyl, a triglyceride-lowering medication that is high in the omega 3 fatty acid, eicosapentaenoic acid, in combination with statins helped to reduce stroke risk by 36% in those with cardiovascular disease.
A new long-term study reveals people who followed diets that were high in plant-based food items and were lower in sugars had a 10% reduced risk of suffering from an ischemic stroke later in life.
The stroke byproduct acrolein activates the precursor of heparanase, an enzyme that degrades the glycocalyx in the blood-brain barrier.
An antibody called HAE-4 targets APOE and removes Alzheimer's related amyloid plaques in mouse models. The antibody improves blood vessel function in the brain without raising the risk of brain bleeds.
Treatment with LAU-0901, a synthetic molecule that blocks pro-inflammatory platelet-activating factor, in addition to aspirin-triggered NPD1, reduced the size of damage areas in the brain, initiated repair mechanisms, and improved behavioral recovery following ischemic stroke.
Repetitive transcranial magnetic stimulation significantly decreases post-stroke depression by increasing brain activity.
The risk of stroke is 54% higher in those who experience symptoms of depression, a news study reports.
Direct carotid puncture is a safe and effective alternative to thrombectomy for stroke patients.